Back to School: How biopharma can reboot drug development. Access exclusive analysis here
SciClone Pharmaceuticals Inc.
Franklin Berger of Josephthal Lyon & Ross reiterated a "buy,"
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury